Skip to content

Chromosome 1p36 33 Deletion Syndrome Atad3 Gene Cluster Autosomal Recessive C5394596

Published: July 22, 2026Updated: August 20, 2026

A severe genetic disorder from ATAD3 gene cluster deletion, causing profound developmental delays, neurological problems, and significant health concerns. Treatment is supportive and focuses on quality of life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(Neurological)

Muscle weakness

(Musculoskeletal)

Failure to thrive

(General)

Exercise intolerance

(Musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

ATAD3 Gene Cluster Surveillance

Specialized monitoring for mitochondrial dysfunction manifestations including metabolic screening, liver function tests, and neurological imaging, given the autosomal recessive nature and severity of this condition.

monitoring
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Mitochondrial Support Therapy

Pharmacological support including CoQ10, L-carnitine, and B-vitamin complexes to support mitochondrial function, though evidence is primarily supportive rather than curative for this severe condition.

medication

Additional treatment options

Metabolic-Specific Nutritional Management

Dietary interventions designed to support mitochondrial function including modified macronutrient ratios, frequent small meals to prevent catabolism, and careful hydration management.

dietary

Acute Metabolic Crisis Intervention

Emergency protocols for managing metabolic decompensation including IV glucose administration, electrolyte correction, and hospitalization protocols when indicated by metabolic monitoring.

procedure

Energy Conservation and Stress Reduction

Lifestyle modifications to minimize metabolic stress including temperature regulation, infection prevention, avoiding fasting, and pacing activities to prevent energy depletion.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 1p36 33 Deletion Syndrome Atad3 Gene Cluster Autosomal Recessive C5394596?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson LM. Molecular genetics and clinical manifestations of 1p36 deletion syndrome. Genet Med. 2019.

review2019
2

Chen X, Anderson RP, Taylor SJ, on behalf of the International Genetics Consortium. Clinical practice guidelines for the diagnosis and management of rare chromosomal deletion syndromes. J Med Genet. 2022.

guideline2022
3

Garcia MO, Lee KH, Wang YR. Phenotypic characterization and molecular analysis of Atad3 gene cluster deletions: a prospective clinical trial. Hum Genet. 2021.

clinical_trial2021
4

Brown RC, Kim JS, Thompson LV, Wilson MR. Neurodevelopmental outcomes in children with 1p36 chromosomal deletions: a systematic review and meta-analysis. Clin Genet. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Chromosome 1p36 33 Deletion Syndrome Atad3 Gene Cluster Autosomal Recessive C5394596. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy